UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.793

Sortiert nach

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

The New England journal of medicine, 2008-09, Vol.359 (12), p.1238-1251

2008

Link zum Volltext

Verfügbarkeit prüfen

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials

Circulation (New York, N.Y.), 2015-04, Vol.131 (17), p.1486-1494

2015

Link zum Volltext

Verfügbarkeit prüfen

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Journal of the American College of Cardiology, 2007-07, Vol.50 (1), p.40-47

2007

Link zum Volltext

Verfügbarkeit prüfen

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Circulation (New York, N.Y.), 2007-09, Vol.116 (13), p.1482-1487

2007

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1997-2004

2006

Link zum Volltext

Verfügbarkeit prüfen

Albuminuria in chronic heart failure: prevalence and prognostic importance

The Lancet (British edition), 2009-08, Vol.374 (9689), p.543-550

2009

Link zum Volltext

Verfügbarkeit prüfen

Body mass index and prognosis in patients with chronic heart failure : Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-08, Vol.116 (6), p.627-636

2007

Link zum Volltext

Verfügbarkeit prüfen

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

The Lancet (British edition), 2005-12, Vol.366 (9502), p.2005-2011

2005

Link zum Volltext

Verfügbarkeit prüfen

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

The New England journal of medicine, 2008-09, Vol.359 (12), p.1225-1237

2008

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Circulation (New York, N.Y.), 2007-06, Vol.115 (24), p.3111-3120

2007

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

PloS one, 2015-07, Vol.10 (7), p.e0133236-e0133236

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

Journal of the American College of Cardiology, 2007-11, Vol.50 (20), p.1959-1966

2007

Link zum Volltext

Verfügbarkeit prüfen

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Circulation (New York, N.Y.), 2007-03, Vol.115 (11), p.1371-1375

2007

Link zum Volltext

Verfügbarkeit prüfen

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Circulation (New York, N.Y.), 2004-10, Vol.110 (17), p.2618-2626

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of Candesartan on cause-specific Mortality in heart failure patients. The Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Circulation (New York, N.Y.), 2004-10, Vol.110 (15), p.2180-2183

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis

British journal of clinical pharmacology, 2006-11, Vol.62 (5), p.527-537

2006

Link zum Volltext

Verfügbarkeit prüfen

Dabigatran etexilate

Nature reviews. Drug discovery, 2008-07, Vol.7 (7), p.557-558

2008

Link zum Volltext

Verfügbarkeit prüfen

Effect of Baseline Cognitive Function and Antihypertensive Treatment on Cognitive and Cardiovascular Outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

American journal of hypertension, 2005-08, Vol.18 (8), p.1052-1059

2005

Link zum Volltext

Verfügbarkeit prüfen

Targeting Topoisomerase I in the Era of Precision Medicine

Clinical cancer research, 2019-11, Vol.25 (22), p.6581-6589

2019

Link zum Volltext

Verfügbarkeit prüfen

Design of amidobenzimidazole STING receptor agonists with systemic activity

Nature (London), 2018-12, Vol.564 (7736), p.439-443

2018

Link zum Volltext

Verfügbarkeit prüfen

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

Journal of hypertension, 2003-05, Vol.21 (5), p.875-886

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.77

2009

Link zum Volltext

Verfügbarkeit prüfen

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

The New England journal of medicine, 2018-01, Vol.378 (4), p.354-369

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

European journal of medicinal chemistry, 2017-01, Vol.126, p.705-753

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.793

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.680)
Mit Volltextzugriff
(5.177)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Benzimidazoles - Therapeutic Use
(6.835)
Humans
(5.885)
Science & Technology
(5.645)
Life Sciences & Biomedicine
(5.539)
Male
(3.618)
Female
(3.440)
Animals
(2.658)
Middle Aged
(2.165)
Aged
(1.721)
Adult
(1.662)
Biological And Medical Sciences
(1.391)
Benzimidazoles - Pharmacology
(1.384)
Medical Sciences
(1.353)
Treatment Outcome
(1.315)
Benzimidazoles - Administration & Dosage
(1.191)
Benzimidazoles - Adverse Effects
(1.189)
Cardiovascular System & Cardiology
(1.115)
Pharmacology & Pharmacy
(1.077)
Hypertension - Drug Therapy
(982)
Tetrazoles - Therapeutic Use
(965)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Albuminuria in chronic heart failure: prevalence and prognostic importance

Body mass index and prognosis in patients with chronic heart failure : Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure : Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program

Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Mortality and morbidity reduction with candesartan in patients with chronic heart failure and Left ventricular systolic dysfunction : Results of the CHARM low-left ventricular ejection fraction trials

Effect of Candesartan on cause-specific Mortality in heart failure patients. The Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis

Dabigatran etexilate

Effect of Baseline Cognitive Function and Antihypertensive Treatment on Cognitive and Cardiovascular Outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

Targeting Topoisomerase I in the Era of Precision Medicine

Design of amidobenzimidazole STING receptor agonists with systemic activity

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

Suchergebnisse filtern